Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA’s Drug Approval Norms Could Be Upended In Second Trump Term
Nov 07 2024
•
By
Sarah Karlin-Smith
FDA drug approval norms could be shattered during Trump's second presidency.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Elections
More from Vaccines